Drug Research
Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services
Aragen Life Sciences (formerly, GVK BIO), a leading partner offering R&D and Manufacturing solutions (CRO/CDMO) for life sciences industries worldwide, expects high teens growth in 2022, with NCE development and manufacturing business growing at circa 40% year-on-year.
The company, states...
Drug Research
AbbVie, University of Chicago Extend Research Collaboration to Support Preclinical Oncology Research Through 2025
AbbVie and the University of Chicago and have extended their collaboration agreement through 2025 to support preclinical oncology research.
To date, the collaboration has led to novel insights related to biomarkers and therapeutic applications for existing AbbVie programs. This has...
Drug Research
Biognosys Launches Next-Generation Blood Biomarker Discovery Solution
Biognosys, a leader in proteomics solutions for drug discovery and development, announces the launch of its next-generation blood biomarker discovery solution, which will be offered as a contract research service. The service is designed to help researchers decipher the...
Drug Research
Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States
Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the United States upon approval. Rimegepant is commercialized as Nurtec® ODT in the U.S., and is indicated for the acute...
Drug Research
Phillips-Medisize and Exact Sciences Collaborate to Fight Colorectal Cancer
Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, announces the successful collaboration with Exact Sciences, a global leader in cancer diagnostics, to advance early cancer detection. Fueled by a relentless pursuit for smarter, earlier...
Drug Research
Standigm Established a Synthetic Research Center to Improve Efficiency of AI Drug Discovery
Standigm Inc., the leading workflow artificial intelligence (AI) drug discovery company, announced that the company had established a Synthetic Research Center in the headquarters of SK Chemicals Co., Ltd, a life science and green chemicals company.
Standigm has dramatically improved...
Drug Research
IFF Displays Innovative Pharmaceutical Solutions, Tailored to Address Current, Future Industry Challenges
As the pharmaceutical industry continues to evolve – introducing increasingly complex drugs, unique applications and new dosage forms – the Pharma Solutions division of IFF is dedicated to helping formulators and manufacturers evolve alongside it. Armed with extensive expertise...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read